Former Fallen London lead designer, and Skin Deep, Pathologic 2, and Where the Water Tastes Like Wine writer Bruno Dias! Cheers Bruno! Mind if we have a nose at your bookshelf?

HER2+ breast cancer usually undergo pre-operative therapy with multi-agent chemotherapy in combination with anti-HER2 ...

HER2+ breast cancer usually undergo preoperative therapy with multi-agent chemotherapy in combination with anti-HER2 ...

Dystrophin's isoforms are thought to contribute variably to neuropsychiatric disorders, behavioral disorders, and ...

Daiichi Sankyo Company Limited (OTC:DSNKY) and AstraZeneca (NASDAQ:AZN) announced promising results from 3 clinical trials: ...

Results from a phase 3 clinical trial published in the New England Journal of Medicine, today (June 2nd) show that patients ...

CHICAGO -- A neoadjuvant chemotherapy regimen of cisplatin (Platinol), nab-paclitaxel (Abraxane), capecitabine (Xeloda), and ...

Explore how cutting-edge agents like alpelisib, capivasertib, MEK and ERK inhibitors, and JAK inhibitors are reshaping the ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced the presentation of new clinical results from the PREDICT DNA and SCANDARE studies highlighting the ...

Use of adjuvant regimens with single-cytotoxic agents among women with stage II-III HER2-positive breast cancer. Key predictive features and their contribution to Pathologic Complete Response (pCR) ...

These horror games won't shoehorn you into a linear narrative-driven experience, instead offering robust player freedom to ...

Results from a Phase III clinical trial published in the New England Journal of Medicine, show that patients with lung cancer ...